These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 18601742)

  • 1. Polymorphisms of selected xenobiotic genes contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Ibrahim M; Al-Rasheed M; Abubaker J; Bu R; Siddiqui SU; Al-Dayel F; Al-Sanea O; Al-Nuaim A; Uddin S; Al-Kuraya K
    BMC Med Genet; 2008 Jul; 9():61. PubMed ID: 18601742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in xenobiotic-metabolizing genes and the risk of chronic lymphocytic leukemia and non-Hodgkin's lymphoma in adult Russian patients.
    Gra OA; Glotov AS; Nikitin EA; Glotov OS; Kuznetsova VE; Chudinov AV; Sudarikov AB; Nasedkina TV
    Am J Hematol; 2008 Apr; 83(4):279-87. PubMed ID: 18061941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined GSTM1 and GSTT1 null genotypes are associated with a lower risk of papillary thyroid cancer.
    Lemos MC; Coutinho E; Gomes L; Carrilho F; Rodrigues F; Regateiro FJ; Carvalheiro M
    J Endocrinol Invest; 2008 Jun; 31(6):542-5. PubMed ID: 18591888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
    Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
    Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of drug-metabolizing enzymes CYP1A1, GSTT and GSTP contribute to the development of diffuse large B-cell lymphoma risk in the Saudi Arabian population.
    Al-Dayel F; Al-Rasheed M; Ibrahim M; Bu R; Bavi P; Abubaker J; Al-Jomah N; Mohamed GH; Moorji A; Uddin S; Siraj AK; Al-Kuraya K
    Leuk Lymphoma; 2008 Jan; 49(1):122-9. PubMed ID: 18203021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of GST and NAT2 polymorphisms in thyroid cancer.
    Hernández A; Xamena N; Surrallés J; Galofré P; Velázquez A; Creus A; Marcos R
    J Endocrinol Invest; 2008 Nov; 31(11):1025-31. PubMed ID: 19169061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD52 polymorphisms contribute to the development of papillary thyroid cancer susceptibility in Middle Eastern population.
    Siraj AK; Al-Rasheed M; Ibrahim M; Siddiqui K; Al-Dayel F; Al-Sanea O; Uddin S; Al-Kuraya K
    J Endocrinol Invest; 2008 Oct; 31(10):893-9. PubMed ID: 19092295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microarray-based detection of CYP1A1, CYP2C9, CYP2C19, CYP2D6, GSTT1, GSTM1, MTHFR, MTRR, NQO1, NAT2, HLA-DQA1, and AB0 allele frequencies in native Russians.
    Gra O; Mityaeva O; Berdichevets I; Kozhekbaeva Z; Fesenko D; Kurbatova O; Goldenkova-Pavlova I; Nasedkina T
    Genet Test Mol Biomarkers; 2010 Jun; 14(3):329-42. PubMed ID: 20373852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphisms of methylenetetrahydrofolate reductase and glutathione S-transferase are not associated with the risk of papillary thyroid cancer in Korean population.
    Kweon SS; Shin MH; Kim HN; Kim SH; Kang HC
    Mol Biol Rep; 2014 Jun; 41(6):3793-9. PubMed ID: 24535271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aromatic DNA adducts and polymorphisms of CYP1A1, NAT2, and GSTM1 in breast cancer.
    Firozi PF; Bondy ML; Sahin AA; Chang P; Lukmanji F; Singletary ES; Hassan MM; Li D
    Carcinogenesis; 2002 Feb; 23(2):301-6. PubMed ID: 11872636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of xenobiotic-metabolizing genes polymorphisms with cervical cancer risk in the Tunisian population.
    Helaoui A; Sfar S; Boudhiba N; Dehghanian F; Dehbashi M; Bouchahda H; Hojati Z; Kenani A
    Mol Biol Rep; 2023 Feb; 50(2):949-959. PubMed ID: 36376536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Markers of genetic susceptibility in human environmental hygiene and toxicology: the role of selected CYP, NAT and GST genes.
    Thier R; Brüning T; Roos PH; Rihs HP; Golka K; Ko Y; Bolt HM
    Int J Hyg Environ Health; 2003 Jun; 206(3):149-71. PubMed ID: 12872524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Phase I (CYPs) and Phase II (GSTs) Gene Polymorphisms and Their Interaction with Environmental Factors in Nasopharyngeal Cancer from the Ethnic Population of Northeast India.
    Singh SA; Ghosh SK
    Pathol Oncol Res; 2019 Jan; 25(1):33-44. PubMed ID: 28952035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tobacco carcinogen-metabolizing genes CYP1A1, GSTM1, and GSTT1 polymorphisms and their interaction with tobacco exposure influence the risk of head and neck cancer in Northeast Indian population.
    Choudhury JH; Singh SA; Kundu S; Choudhury B; Talukdar FR; Srivasta S; Laskar RS; Dhar B; Das R; Laskar S; Kumar M; Kapfo W; Mondal R; Ghosh SK
    Tumour Biol; 2015 Aug; 36(8):5773-83. PubMed ID: 25724184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer.
    Sachse C; Smith G; Wilkie MJ; Barrett JH; Waxman R; Sullivan F; Forman D; Bishop DT; Wolf CR;
    Carcinogenesis; 2002 Nov; 23(11):1839-49. PubMed ID: 12419832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of xenobiotic metabolizing gene polymorphisms in breast cancer susceptibility and treatment outcome.
    Chacko P; Joseph T; Mathew BS; Rajan B; Pillai MR
    Mutat Res; 2005 Mar; 581(1-2):153-63. PubMed ID: 15725614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.
    Sreeja L; Syamala V; Hariharan S; Madhavan J; Devan SC; Ankathil R
    J Hum Genet; 2005; 50(12):618-27. PubMed ID: 16228113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A1, CYP2D6, CYP2E1, NAT2, GSTM1 and GSTT1 polymorphisms or their combinations are associated with the increased risk of the laryngeal squamous cell carcinoma.
    Gajecka M; Rydzanicz M; Jaskula-Sztul R; Kujawski M; Szyfter W; Szyfter K
    Mutat Res; 2005 Jul; 574(1-2):112-23. PubMed ID: 15914211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential effect of gender in combination with common genetic polymorphisms of drug-metabolizing enzymes on the risk of developing acute leukemia.
    Bolufer P; Collado M; Barragán E; Cervera J; Calasanz MJ; Colomer D; Roman-Gómez J; Sanz MA
    Haematologica; 2007 Mar; 92(3):308-14. PubMed ID: 17339179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.